Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êîñìåòîëîãèÿ-äåðìàòîëîãèÿ

Êîñìåòîëîãèÿ-äåðìàòîëîãèÿ Ôîðóìû: ×àñòî çàäàâàåìûå âîïðîñû, Ôîðóì äëÿ âðà÷åé, Àëîïåöèÿ, Ãåðïåñ - äèàãíîñòèêà è ëå÷åíèå

Çàêðûòàÿ òåìà
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 26.06.2003, 11:15
dtm dtm âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 16.06.2003
Ãîðîä: Òîëüÿòòè
Ñîîáùåíèé: 17
dtm ýòîò ó÷àñòíèê èìååò îòâðàòèòåëüíóþ ðåïóòàöèþ íà ôîðóìå
ëå÷åíèå íåéðîäåðìèòà

Óâàæàåìûé An, êî âñåìó íàïèñàííîìó ìíå õîòåëîñü áû äîáàâèòü ñëåäóþùåå:
- òàêèå èçìàòûâàþùèå ÷åëîâåêà áîëåçíè, êàê ýêçåìà, ïñîðèàç, íåéðîäåðìèò õîðîøî ïîääàþòñÿ ëå÷åíèþ ñ ïîìîùüþ äèåòû è ëå÷åíèÿ ïðåïàðàòàìè ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ. Êîíå÷íî, îñíîâíîå ëå÷åíèå äîëæíî áûòü èíäèâèäóàëüíûì â çàâèñèìîñòè îò ïðè÷èíû, ïðèâåäøåé ê âîçíèêíîâåíèþ çàáîëåâàíèÿ. Íî èñêëþ÷åíèå èç ðàöèîíà ìàðãàðèíà è äðóãèõ ïðîäóêòîâ, ñîäåðæàùèõ òðàíñæèðíûå êèñëîòû (íàïðèìåð, ãèäðîãåíèçèðîâàííûå ðàñòèòåëüíûå ìàñëà), ïðîâîäèò ê óìåíüøåíèþ îáîñòðåíèé. Äàííûå áîëåçíè òàêæå õîðîøî ïîääàþòñÿ ëå÷åíèþ ïðè èñïîëüçîâàíèè ãàììà-ëèíîëåíîâîé (ÃËÊ) è ýéêîçïåàíòåíîâîé (ÝÏÊ) êèñëîò, - ïîñêîëüêó âû íå ïåðåíîñèòå ðûáó, êóïèòå â àïòåêå "Ïîëèíåíàñûùåííûå æèðíûå êèñëîòû".
Ñàìûå ñëîæíûå è óïîðíûå êîæíûå çàáîëåâàíèÿ íà÷èíàþò âåñòè ñåáÿ èíà÷å, åñëè ïðîâåñòè ìîùíóþ äåçèíòîêñèêàöèþ îðãàíèçìà, èñïîëüçóÿ ïðîòèâîïàðàçèòàðíûå ðàñòèòåëüíûå ýíòåðîñîðáåíòû ñ ïîñëåäóþùèì âîññòàíîâëåíèåì ìåñòíîãî èììóíèòåòà â êèøå÷íèêå.
Êàê ïðàâèëî, ëå÷åíèå çàáîëåâàíèé êîæè íå îáõîäèòñÿ áåç âîññòàíîâëåíèÿ è ëå÷åíèÿ öåíòðàëüíîé è ïåðèôåðè÷åñêîé íåðâíîé ñèñòåìû.
ÍÅÉÐÎÄÅÐÌÈÒ òðåáóåò îáÿçàòåëüíîãî óñòàíîâëåíèÿ âåðîÿòíîé ïðè÷èíû çàáîëåâàíèÿ. Íåîáõîäèìî ñîñòàâèòü èíäèâèäóàëüíóþ äèåòó.  ïèòàíèè äîëæíû áûòü îãðàíè÷åíû óãëåâîäû, óìåíüøåíî êîëè÷åñòâî ñïåöèé è ïðÿíîñòåé, ïî âîçìîæíîñòè èñêëþ÷èòü îñòðûå áëþäà.
Ëå÷åíèå äîëæíî áûòü ìåñòíûì è îáùèì. Îáùåå ëå÷åíèå âêëþ÷àåò â ñåáÿ íåñêîëüêî ýòàïîâ:

1. Äåãåëüìèíòèçàöèÿ (î÷èùåíèå îðãàíèçìà îò ãëèñòîâ è ñîïðîâîëæäàþùèõ èõ ïàðàçèòîâ), ïðåïàðàòû äîëæíû ñîäåðæàòü òàêèå òðàâû, êàê ÷àáðåö, ïîëûíü, ïèæìà, êðóøèíà, çâåðîáîé, ñïîðûø, õìåëü, ìÿòà ïåðå÷íàÿ, òûñÿ÷åëèñòíèê...
Âàæíà ñàíàöèÿ õðîíè÷åñêèõ î÷àãîâ èíôåêöèè; âîññòàíîâëåíèå îáåçâðåæèâàþùèõ ñèñòåì ïå÷åíè - ïðåïàðàòû íà îñíîâå ñîëÿíêè õîëìîâîé.
2. Íîðìàëèçàöèÿ òîíóñà öåíòðàëüíîé íåðâíîé ñèñòåìû.Îñîáîå çíà÷åíèå ïðèîáðåòàþò ïðåïàðàòû, ñîäåðæàùèå âñþ ãðóïïó âèòàìèíâ Â, òðàâû: ïóñòûðíèê, ïèîí, õìåëü, äóøèöà, êèïðåé, à òàêæå ËÅÖÈÒÈÍ, êîòîðûé âîññòàíîâëèâàåò ìèåëèíèçàöèþ íåðâíûõ âîëîêîí, ïîâðåæäåííûõ ïàðàçèòàìè.
3. Èñïîëüçóþòñÿ ïðåïàðàòû, óëó÷øàþùèå òðîôè÷åñêèå ôóíêöèè êîæè: íàòóðàëüíûé ÁÅÒÀ-ÊÀÐÎÒÈÍ, òå æå "Ïîëèíåíàñûùåííûå æèðíûå êèñëîòû".
4. Çàâåðøàåòñÿ ëå÷åíèå êóðñîì ïðîáèîòèêîâ (àöèäîáêàòåðèè è áèôèäîáàêòåðèè). Çäåñü íå èìåþòñÿ ââèäó êèñëîìîëî÷íûå ïðîäóêòû ñ áèôèäîáàêòåðèÿìè - ýòè áèôèäîáàêòåðèè ðàáîòàþò òîëüêî â æåëóäêå, íå äîñòèãàÿ êèøå÷íèêà.
Èñêëþ÷èòå èç ðàöèîíà ñàõàð, ïîñêîëüêó îí ÿâëÿåòñÿ èñòî÷íèêîì «òîïëèâà» äëÿ áîëåçíåòâîðíûõ ìèêðîîðãàíèçìîâ æåëóäî÷íî-êèøå÷íîãî òðàêòà, ñïîñîáñòâóåò èõ ðîñòó è ðàçìíîæåíèþ, ÷òî ñîïðîâîæäàåòñÿ óñèëåíèåì èíòîêñèêàöèè è åùå áîëüøèì ñíèæåíèåì áàðüåðíûõ è áàêòåðèöèäíûõ ñâîéñòâ êîæè.
È ïîñëåäíåå, îáðàáàòûâàéòå ïîðàæåííûå ó÷àñòêè êîæè êðåìîì ñ äîáàâëåíèåì íàòóðàëüíûõ ÁÅÒÀ-ÊÀÐÎÒÈÍÀ, ÂÈÒÀÌÈÍÀ «Å», è êîëëîèäíîãî ñåðåáðà.
  #17  
Ñòàðûé 26.06.2003, 12:59
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìàÿ Òàìàðà!
ß ïðîøó ïðîùåíèÿ, íî Âû îïÿòü íå òàì âûñòóïàåòå. Ðàçäåë ïðî ÁÀÄ çäåñü:
http://forums.rusmedserv.com/forumd...3?s=&forumid=23

Ê äåðìàòîëîãèè ÁÀÄû íå èìàþò íèêàêîãî îòíîøåíèÿ. Òàê æå êàê è íåñóùåñòâóþùèå ãëèñòû è çàãàäî÷íûå ñîïðîâîæäàþùèå èõ ïàðàçèòû. Íå ââîäèòå ïàöèåíòîâ â çàáëóæäåíèå.
Ñïàñèáî.


P.S. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Treating Atopic Dermatitis

Treatment involves a partnership among the patient, family members, and doctor. The doctor will suggest a treatment plan based on the patient’s age, symptoms, and general health. The patient and the patient’s family play a large role in the success of the treatment plan by carefully following the doctor’s instructions. Some of the primary components of treatment programs are described below. Most patients can be successfully treated with proper skin care and lifestyle changes and do not require the more intensive treatments discussed.

The doctor has three main goals in treating atopic dermatitis: healing the skin and keeping it healthy, preventing flares, and treating symptoms when they do occur. Much of caring for the skin and preventing flares has to do with developing skin care routines, identifying exacerbating factors, and avoiding circumstances that trigger the skin’s immune system and the itch-scratch cycle. It is important for the patient and his or her family to note any changes in skin condition in response to treatment, and to be persistent in identifying the most effective treatment strategy.

Skin Care: Healing the skin and keeping it healthy are of primary importance as part of both preventing further damage and enhancing quality of life. Developing and sticking with a daily skin care routine is critical to preventing flares. Key factors are proper bathing and the application of lubricants, such as creams or ointments, within 3 minutes of bathing. People with atopic dermatitis should avoid hot or long (more than 10 to 15 minutes) baths and showers. A lukewarm bath helps to cleanse and moisturize the skin without drying it excessively. Because soaps can be drying to the skin, the doctor may recommend limited use of a mild bar soap or nonsoap cleanser. Bath oils are not usually helpful.

Once the bath is finished, the patient should air-dry the skin, or pat it dry gently (avoiding rubbing or brisk drying), and apply a lubricant immediately. Lubrication restores the skin’s moisture, increases the rate of healing, and establishes a barrier against further drying and irritation. Several kinds of lubricants can be used. Lotions have a high water or alcohol content and evaporate more quickly, so they generally are not the best choice. Creams and ointments work better at healing the skin. Tar preparations can be very helpful in healing very dry, lichenified areas. Whatever preparation is chosen, it should be as free of fragrances and chemicals as possible.

Another key to protecting and restoring the skin is taking steps to avoid repeated skin infections. Although it may not be possible to avoid infection altogether, the effect of an infection may be minimized if it is identified and treated early. People with atopic dermatitis and their families should learn to recognize signs of skin infections, including tiny pustules (pus-filled bumps) on arms and legs, appearance of oozing areas, or crusty yellow blisters. If symptoms of a skin infection develop, the doctor should be consulted and treatment should begin as soon as possible.

Treating Atopic Dermatitis in Infants and Children

Give brief, lukewarm baths.

Apply lubricant immediately following the bath.

Keep child’s fingernails filed short.

Select soft cotton fabrics when choosing clothing.

Consider using antihistamines to reduce scratching at night.

Keep the child cool; avoid situations where overheating occurs.

Learn to recognize skin infections and seek treatment promptly.

Attempt to distract the child with activities to keep him or her from scratching.



Medications and Phototherapy: If a flare of atopic dermatitis does occur, several methods can be used to treat the symptoms. The doctor will select a treatment according to the age of the patient and the severity of the symptoms. With proper treatment, most symptoms can be brought under control within 3 weeks. If symptoms fail to respond, this may be due to a flare that is stronger than the medication can handle, a treatment program that is not fully effective for a particular individual, or the presence of trigger factors that were not addressed in the initial treatment program. These factors can include a reaction to a medication, infection, or emotional stress. Continued symptoms may also occur because the patient is not following the treatment program instructions.

Corticosteroid creams and ointments are the most frequently used treatment. Sometimes over-the-counter preparations are used, but in many cases the doctor will prescribe a stronger corticosteroid cream or ointment. The doctor will take into account the patient’s age, location of the skin to be treated, severity of the symptoms, and type of preparation (cream or ointment) when prescribing a medication. Sometimes the base used in certain brands of corticosteroid creams and ointments is irritating for a particular patient. Side effects of repeated or long-term use of topical corticosteroids can include thinning of the skin, infections, growth suppression (in children), and stretch marks on the skin.

Some treatments reduce specific symptoms of the disease. Antibiotics to treat skin infections may be applied directly to the skin in an ointment, but are usually more effective when taken by mouth. Certain antihistamines that cause drowsiness can reduce nighttime scratching and allow more restful sleep when taken at bedtime. This effect can be particularly helpful for patients whose nighttime scratching makes the disease worse. If viral or fungal infections are present, the doctor may also prescribe medications to treat those infections.

Phototherapy (treatment with light) that uses ultraviolet A or B light waves, or both together, can be an effective treatment for mild to moderate dermatitis in older children (over 12 years old) and adults. Photochemotherapy, a combination of ultraviolet light therapy and a drug called psoralen, can also be used in cases that are resistant to phototherapy alone. Possible long-term side effects of this treatment include premature skin aging and skin cancer. If the doctor thinks that phototherapy may be useful to treat the symptoms of atopic dermatitis, he or she will use the minimum exposure necessary and monitor the skin carefully.

When other treatments are not effective, the doctor may prescribe systemic corticosteroids: drugs that are taken by mouth or injected into muscle instead of being applied directly to the skin. An example of a commonly prescribed corticosteroid is prednisone. Typically, these medications are used only in resistant cases and only given for short periods of time. The side effects of systemic corticosteroids can include skin damage, thinned or weakened bones, high blood pressure, high blood sugar, infections, and cataracts. It can be dangerous to suddenly stop taking corticosteroids, so it is very important that the doctor and patient work together in changing the corticosteroid dose.

In adults, immunosuppressive drugs, such as cyclosporine, are also used to treat severe cases of atopic dermatitis that have failed to respond to any other forms of therapy. Immunosuppressive drugs restrain the overactive immune system by blocking the production of some immune cells and curbing the action of others. The side effects of cyclosporine can include high blood pressure, nausea, vomiting, kidney problems, headaches, tingling or numbness, and a possible increased risk of cancer and infections. There is a risk of relapse after the drug is stopped. Because of their toxic side effects, systemic corticosteroids and immunosuppressive drugs are used only in severe cases and then for as short a period of time as possible. Patients requiring systemic corticosteroids should be referred to dermatologists or allergists specializing in the care of atopic dermatitis to help identify trigger factors and alternative therapies.

In rare cases, when no other treatments have been successful, the patient may have to be hospitalized. A 5- to 7-day stay in the hospital allows intensive skin care and reduces the patient’s exposure to irritants and allergens and the stresses of day-to-day life. Under these conditions, the symptoms usually clear quickly if environmental factors play a role or if the patient is not able to carry out adequate skin care at home.

A number of promising experimental medications are being tested for atopic dermatitis. These medications affect the immune system and offer additional options for patients with difficult-to-treat symptoms.
  #18  
Ñòàðûé 02.12.2003, 13:46
Olenushka Olenushka âíå ôîðóìà
Ñåðôåð
 
Ðåãèñòðàöèÿ: 02.09.2003
Ñîîáùåíèé: 9
Olenushka *
Íà îïûòå ìîåé ïîäðóãè ìîãó òîëüêî íàïîìíèòü î öåëåáíîì ýôôåêòå êëèìàòîòåðåïèè. Îíà ñòðàäàë äîëãî è ïîðàæåíèÿ êîæè íàïîìèíàëè îïèñàííûå Âàìè. Ìû åçäèëè â ãîðîä Ñàêè íà ×åðíîå ìîðå, îêîëî Åâïàòîðèè. Òàì åñòü ñîëåíîå îçåðî, ãðÿçåâîå. Êóïàíèé â íåì, à òàêæå â ìîðå, õâàòèëî íà 2 ãîäà ïîääåðæàíèÿ êîæè â íîðìàëüíîì ñîñòîÿíèè. Ìîé ðåáåíîê , óâû, òîæå àòîïèê. Âåçåì åãî áóäóùèì ëåòîì òóäà (åé ïî÷òè áóäåò 2 ãîäà), ýòî ïîñëåäíÿÿ íàäåæäà(
Æåëàþ Âàì óäà÷è â ëå÷åíèè!!!
  #19  
Ñòàðûé 22.03.2005, 15:10
Àâàòàð äëÿ Magri
Magri Magri âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.11.2004
Ãîðîä: Çåëåíîãðàä
Ñîîáùåíèé: 27
Magri ýòîò ó÷àñòíèê èìååò ïëîõóþ ðåïóòàöèþ íà ôîðóìå
Ê ñîæàëåíèþ âûåçä íà þã ýòî íå ïàíàöåÿ îò íåéðîäåðìèòà - íà ñîáñòâåííîì ïðèìåðå ìîãó ýòî óòâåðæäàòü - äà, ïîìîãàåò íà êàêîå-òî âðåìÿ, ïîêà ÷åëîâåê íå âîçâðàùàåòñÿ äîìîé, à òàì ïîíåñëîñü âñå ïî-íîâîìó...ñîëíöå è ìîðå âíåøíå âîçäåéñòâóþò, à ïðè÷èíû çàáîëåâàíèÿ (ïî çàâåðåíèþ âðà÷åé è ëå÷åáíîé ëèòåðàòóðû) ëåæàò âíóòðè îðãàíèçìà!
 äàííûé ìîìåíò ó ìåíÿ íà÷àëîñü î÷åðåäíîå îáîñòðåíèå íåéðîäåðìèòà, ñíà÷àëà âðà÷ âûïèñàë ãîðìîíàëüíóþ ìàçü Àäâàíòàí, àíòèãèñòàìèííûé ïðåïàðàò Çèðòåê, Àñêîðóòèí è óêîëû âèòàìèíîâ ãðóïïû  (Â1,Â6, Â12)...íî ïîä êîíåö óêîëîâ, ó ìåíÿ âûñûïàëà íà ðóêàõ åùå äîïîëíèòåëüíî àëëåðãèÿ, ïðèøëîñü ñíîâà èäòè ê âðà÷ó, è òî ÷òî îí ìíå ïîñîâåòîâàë âûçâàëî ëèøü èñòåðè÷åñêèé ñìåõ, ñîçäàåòñÿ îùóùåíèå, ÷òî âðà÷è ñàìè òîëêîì íå çíàþò ÊÀÊ ïðàâèëüíî ëå÷èòü, ïîñòîÿííî ñëûøàòñÿ ñîâåòû òèïà...íó ïîïðîáóéòå ýòî, íå ïîìîãàåò? à, íó çíà÷èò ýòî...ñíîâà íå ïîìîãàåò? íó âû íå îò÷àèâàéòåñü...ïîïðîáóéòå òîãäà äîðîãîñòîÿùèå ïèùåâûå äîáàâêè...âûëå÷èòåñü ïîëíîñòüþ! îò íåéðîäåðìèòà? ÏÎËÍÎÑÒÜÞ?! È ýòî ãîâîðèò äèïëîìèðîâàííûé ñïåöèàëèñò...êîðî÷å ïëþíóëà ÿ íà âñå è ïîçâîíèëà ÷óòü ëè íå ñî ñëåçàìè íà ãëàçàõ ìàìèíîé ïîäðóãå - îíà íåâðîïàòîëîã, íî ñ ìîåé ïðîáëåìîé çíàêîìà äàâíî...íà ÷òî îíà ìíå ñîîáùèëà, äîðîãàÿ äà òû óæå ñàìà äîëæíà êàê ïðîôåññîð âî âñåì ðàçáèðàòüñÿ! Ïîñîâåòîâàëà ñòðîãóþ äèåòó (ÿ ñåé÷àñ åùå è ïîñò ñîáëþäàþ), îòãîâîðèëà îò ëþáîãî èñïîëüçîâàíèÿ ãîðìîíàëüíûõ ñðåäñòâ, äàæå àäâàíòàíîì - ãîðìîíû äåéñòâèòåëüíî ïîìîãàþò è ðåçóëüòàò âèäåí ñðàçó, ÍÎ åñòü è îòðèöàòåëüíûå ñòîðîíû - ïðèâûêàíèå! È èçëå÷åíèå ïðåâðàòèòñÿ â ïîñòîÿííûé ïîèñê âñå íîâûõ è íîâûõ ìàçåé, òàê êàê ñòàðûå áóäóò ïîìîãàòü âñå õóæå è õóæå. Åùå îíà ìíå ïîñîâåòîâàëà íå ìûòü ïî âîçìîæíîñòè ðóêè âîäîé, à ñïîëàñêèâàòü èõ îáûêíîâåííîé ÷àéíîé çàâàðêîé – îíà îòëè÷íî ïîäñóøèâàåò êîðî÷êè. Ê òîìó æå ÿ ñåé÷àñ ïðèíèìàþ àíòèãèñòàìèí ïåðâîãî ïîêîëåíèÿ –ñóïðàñòèí è, äëÿ âûâåäåíèÿ òîêñè÷åñêèõ âåùåñòâ èç îðãàíèçìà, – ïðåïàðàò ýíòåðîñãåëü. Íà íî÷ü îáÿçàòåëüíî áèíòóþ ðóêè, ÷òîáû íå áûëî ñîáëàçíà èõ ðàñ÷åñûâàòü. Åùå ïðîõîæó êóðñ óêîëîâ Ãëþêîíàòà êàëüöèÿ, ïðàâäà âíóòðèìûøå÷íî - âèäíî âðà÷ó íå ïîíðàâèëèñü ìîè âåíû...
Íà òàêîì ëå÷åíèè ÿ ïîêà îêîëî 6 äíåé – åñòü íåáîëüøèå óëó÷øåíèÿ, ÷òî áóäåò äàëüøå ïîêàæåò òîëüêî âðåìÿ è ìîé æèçíåííûé íàñòðîé
  #20  
Ñòàðûé 28.11.2010, 20:23
Mega18 Mega18 âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 28.11.2010
Ãîðîä: Almaty
Ñîîáùåíèé: 2
Mega18 *
íåéðîäåðìèò

õîòåëîñü áû ïðîäîëæèòü òåìó íåéðîäåðìèòà - An, Magri ïîäåëèòåñü îïûòîì, êàê âû ñåáÿ ÷óâñòâóåòå ñåé÷àñ? ìîæåò âñå-òàêè åñòü ÷óäåñà íà ñâåòå )))) Ìíå 28 ëåò è ÿ òîæå âñþ æèçíü ìó÷àþñü ýòîé áîëåçíüþ, õîòÿ òî ÷òî ó ìåíÿ íåéðîäåðìèò óçíàëà ëåò 6 íàçàä, ðàíüøå âðà÷è ñòàâèëè äèàãíîç àòîïè÷åñêèé äåðìàòèò, à íà÷àëîñü âñå ñ äèàòåçà â äåòñòâå.... ×òî òîëüêî íå ïðîáîâàëà, è êàê âû ïîíÿëè íè÷åãî íå ïîìîãàåò, âåðíåå áûëè âðåìåííûå óëó÷øåíèÿ, íî ñî âðåìåíåì âñå âîçâðàùàåòñÿ. Ïîäñêàæèòå âàøè ìåòîäû ëå÷åíèÿ.
  #21  
Ñòàðûé 28.11.2010, 23:35
_An_ _An_ âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 13.08.2002
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10
_An_ *
Mega18, ìîÿ èñòîðèÿ ïîõîæà íà âàøó: äèàòåç - ýêçåìà - íåéðîäåðìèò - àòîïè÷åñêèé äåðìàòèò. Òî ñèëüíîå îáîñòðåíèå 2003 ãîäà, ñ êîòîðîãî íà÷èíàëàñü ýòà òåìà, ïðîøëî. Äóìàþ, ÷òî îíî áûëî ñâÿçàíî ñ ñèëüíûìè ïåðåæèâàíèÿìè â òîò ïåðèîä (íåñêîëüêî ìåñÿöåâ).
Íî ïîëíîñòüþ êîæà íå î÷èñòèëàñü, è ñåé÷àñ âîçíèêàþò ïîðàæåííûå îáëàñòè - íà òûëüíîé ñòîðîíå ëàäîíåé, ëîêòåâûõ ñãèáàõ, ïîä êîëåíÿìè, íà ïëå÷àõ, ñïèíå, øåå, ëèöå.
Êîãäà ñîâñåì ïðèïð¸ò - èñïîëüçóþ "Ïèàíïèí" (òàêàÿ êèòàéñêàÿ ìàçü), êîòîðóþ ìíå êîãäà-òî ïðîïèñàë ëåêàðü-êèòàåö. Îíà ñíèìàåò ñèëüíûé çóä, ææåíèå è êðàñíîòó, îáëåã÷àåò ñîñòîÿíèå, íî ñîâñåì íå èçëå÷èâàåò.
Ïûòàëñÿ îáðàùàòüñÿ çà ïîìîùüþ ê ïñèõîòåðàïåâòàì, íî ñ íèìè âîîáùå íå ñðîñëîñü: äî òåðàïèè äåëî íå äîøëî, ðàñõîäèëèñü íà ýòàïå ïðåäâàðèòåëüíîãî ðàçãîâîðà. Íî ÿ âñ¸ áîëüøå óòâåðæäàþñü âî ìíåíèè, ÷òî íàøà ïðîáëåìà ñâÿçàíà ñ ïñèõèêîé - ìíîãîëåòíèå íàáëþäåíèÿ è ìíîãèå ïðèìåðû, êîòîðûå çäåñü ïðèâîäèòü äîëãî è íåçà÷åì. Îñòàëàñü ñàìàÿ ìàëîñòü - íàéòè õîðîøåãî ïñèõîòåðàïåâòà è ñèëû èçìåíèòü ñåáÿ.
ß ïîêà ñìèðèëñÿ, ïðèâûê æèòü ñî ñâîèìè "áîëÿ÷êàìè", âûëå÷èòü óæå íå ïûòàþñü.
  #22  
Ñòàðûé 29.11.2010, 16:53
Mega18 Mega18 âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 28.11.2010
Ãîðîä: Almaty
Ñîîáùåíèé: 2
Mega18 *
Öèòàòà:
Ñîîáùåíèå îò _An_ Ïîñìîòðåòü ñîîáùåíèå
Êîãäà ñîâñåì ïðèïð¸ò - èñïîëüçóþ "Ïèàíïèí" (òàêàÿ êèòàéñêàÿ ìàçü), êîòîðóþ ìíå êîãäà-òî ïðîïèñàë ëåêàðü-êèòàåö. Îíà ñíèìàåò ñèëüíûé çóä, ææåíèå è êðàñíîòó, îáëåã÷àåò ñîñòîÿíèå, íî ñîâñåì íå èçëå÷èâàåò.
À ãäå ìîæíî ïðèîáðåñòè òàêóþ ìàçü? ß êñòàòè íåäàâíî òîæå ëå÷èëàñü ïðè ïîìîùè êèòàéñêîé ìåäèöèíû (íà êîòîðûå ÿ âîçëàãàëà íó îîîî÷åíü áîëüøèå íàäåæäû) ñúåçäèëà â Êèòàé, ñõîäèëà ê âðà÷ó (à ìîæåò è íå âðà÷ó, íå çíàþ êàê ïðàâèëüíî íàçûâàåòñÿ, êîðî÷å îíà ëå÷èò òðàâàìè), ïðîïèñàëè ìíå òðàâû íà 1 ìåñÿö ïèòü è ïðèíèìàòü âàííû (ðåçóëüòàò - ñèëüíåéøèå âûñûïàíèÿ, ñêàçàëè ÷òî ýòî íîðìàëüíî, âñå äîëæíî âûéòè íàðóæó, ÷åðåç íåêîòîðîå âðåìÿ îíè ïðîøëè, íî ïîòîì ñíîâà ñòàëè ïîÿâëÿòñÿ, ïðè ýòîì çóä áûë ïîñòîÿííî). Èç-çà ïðîáëåì ñ ÿçûêîì (ïåðåâîä÷èê ïëîõî ãîâîðèë ïî-ðóññêè) îêàçàëîñü ÷òî ÿ íå ñîâñåì ïðàâèëüíî âûïîëíÿëà âñå ïðîöåäóðû. Íàçíà÷èëè åùå ðàç òðàâû, íà ýòîò ðàç äðóãîé ñîñòàâ, ñíîâà ïèëà ìåñÿö, íî ðåçóëüòàò íå óòåøèë, õîòÿ ñïèíà ñòàëà ÷èùå.... Òåïåðü íå çíàþ, ïðîäîëæàòü èëè íåò.
Äðóãèì âåäü ïîìîãàåò êèò.ìåäèöèíà, åñëè äàæå ñàõàðíûé äèàáåò ìîæíî âûëå÷èòü, íåóæåëè íàøà áåäà õóæå?
  #23  
Ñòàðûé 29.11.2010, 17:03
_An_ _An_ âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 13.08.2002
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10
_An_ *
Ðàíüøå ýòà ìàçü ïðîäàâàëàñü â ìîñêîâñêèõ àïòåêàõ, íî ïîòîì ïðîïàëà. Ïîñëåäíèå ïàðòèè ìíå ïðèâîçèëà çíàêîìàÿ èç Êèòàÿ. Åùå îíà íàçûâàåòñÿ "999". Ó íå¸ ñèëüíûé ñïåöèôè÷åñêèé ìåíòîëîâûé çàïàõ, è îùóùåíèÿ ñîîòâåòñòâóþùèå ("îõëàæäåíèå").
Ïîèùèòå, â èíåòå åñòü ïðî íåãî èíôîðìàöèÿ.
  #24  
Ñòàðûé 29.11.2010, 17:13
_An_ _An_ âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 13.08.2002
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10
_An_ *
Ïîèñêàë ñàì. Öåíû, ïî ñðàâíåíèþ ñ êèòàéñêèìè, ñèëüíî "çàðÿæåíû", êîíå÷íî. Åñëè åñòü âîçìîæíîñòü, çàêàæèòå êîìó-íèáóäü ïðèâåçòè èç Êèòàÿ (áëàãî, ñåé÷àñ íàðîäó òóäà ìíîãî ìîòàåòñÿ).
Çàêðûòàÿ òåìà



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 23:43.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.